|
|
||||||||



* Department of Immunology, Jerome Holland Laboratories, American Red Cross, Rockville, MD 20855;
Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, MD 20892; and
University of Cincinnati, Childrens Research Hospital, Cincinnati, OH 45267
Previous studies have shown that insulin receptor substrate (IRS)1 and IRS2 mediate proliferative and antiapoptotic signaling through the IL-4R in 32D cells; however their role in regulating normal B cell responses is not clear. To investigate the role of IRS2 in normal B cell function, we developed IRS2 transgenic (Tg) mice on the C57BL/6 background. Western blot analysis revealed a 2-fold elevation in IRS2 protein levels in Tg+ mice compared with littermate controls and a 3-fold increase in basal tyrosine phosphorylated IRS2 in the absence of IL-4 stimulation. IL-4-induced tyrosine phosphorylation of IRS2 was elevated in Tg+ B cells, whereas IL-4-induced phosphorylation of STAT6 was similar between Tg+ and Tg- B cells. Tg expression of IRS2 had little effect on IL-4-mediated proliferation and no effect on protection from apoptosis. However, production of IgE and IgG1 by Tg+ B cells using standard in vitro conditions was diminished 5060%. Because Ig production in vitro is known to be highly cell concentration-dependent, we performed experiments at different cell concentrations. Interestingly, at very low B cell concentrations (10005000 B cells/well), IgE and IgG1 production by Tg+ B cells was greater than that of controls, whereas at higher cell concentrations (10,00020,000 cells/well) Ig production by Tg+ B cells was less than controls. Furthermore, in vivo immunization with OVA-alum or goat anti-IgD resulted in elevated serum IgE levels in the Tg+ mice. These results indicate that overexpression of IRS2 alters the B cell intrinsic density-dependence of IgE and IgG1 production in vitro and enhances IgE responses in vivo.
This article has been cited by other articles:
![]() |
V. T. Thieu, E. T. Nguyen, B. P. McCarthy, H. A. Bruns, R. Kapur, C.-H. Chang, and M. H. Kaplan IL-4-stimulated NF-{kappa}B activity is required for Stat6 DNA binding J. Leukoc. Biol., August 1, 2007; 82(2): 370 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baudler, J. Baumgartl, B. Hampel, T. Buch, A. Waisman, C. M. Snapper, W. Krone, and J. C. Bruning Insulin-Like Growth Factor-1 Controls Type 2 T Cell-Independent B Cell Response J. Immunol., May 1, 2005; 174(9): 5516 - 5525. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |